Cerebral Perfusion During Neonatal Cardiac Surgery
- Conditions
- Congenital Heart DefectsHypoplastic Left Heart SyndromeAortic Coarctation
- Interventions
- Procedure: Deep Hypothermic Circulatory ArrestProcedure: Antegrade Cerebral Perfusion
- Registration Number
- NCT01032876
- Lead Sponsor
- UMC Utrecht
- Brief Summary
Neonates with a congenital heart defect are often in need of early cardiac surgery. In complex congenital heart defects, cardiopulmonary bypass is usually employed, with or without deep hypothermic circulatory arrest (DHCA). The brain is especially vulnerable to ischemic injury, which puts neonates undergoing complex operations at high risk of neurodevelopmental disorders. Selective antegrade cerebral perfusion (ACP) instead of DHCA during these complex operations may contribute to less cerebral damage, but literature is not conclusive on this issue.
Therefore, the investigators will perform a randomised controlled trial comparing DHCA and ACP in neonatal aortic arch reconstructions, focusing on cerebral damage and neurological outcome.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 37
- Aortic arch reconstruction (diagnosis of hypoplastic left heart syndrome, hypoplastic aortic arch, severe coarctation and/ or interrupted aortic arch)
- Infants <4 months old
- Anticipated arch reconstruction time longer than 60 minutes
- Sedation and intubation especially for the pre-operative MRI-scan of this research project
- Participation in another clinical trial
- Failure of data collection
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Deep Hypothermic Circulatory Arrest Deep Hypothermic Circulatory Arrest - Antegrade Cerebral Perfusion Antegrade Cerebral Perfusion -
- Primary Outcome Measures
Name Time Method New or worsened lesions on postoperative MRI-scan (as compared to pre-operative scan). Approximately 1 week postoperatively
- Secondary Outcome Measures
Name Time Method Mortality within 30 days 30 days postoperatively
Trial Locations
- Locations (1)
UMC Utrecht
🇳🇱Utrecht, Netherlands